V.G. Khlopin Radium Institute

The V.G. Khlopin Radium Institute is a prominent Russian research and production facility specializing in radiochemistry, nuclear physics, and the development of radiopharmaceuticals. Operating as a subsidiary of the Rosatom State Atomic Energy Corporation, the institute is a key player in the production and supply of medical isotopes, including Molybdenum-99, Iodine-131, and Lutetium-177. Its healthcare portfolio focuses on the creation of targeted diagnostic and therapeutic agents for oncology, utilizing both alpha and beta emitters. The institute maintains comprehensive capabilities for the full production cycle of radiopharmaceuticals, from cyclotron and reactor-based isotope generation to GMP-compliant drug formulation. It actively collaborates with clinical centers to advance nuclear medicine applications in cancer treatment and diagnostics.